ALNY vs COCO · P/E 76, rev $2.25B vs P/E 60, $4.75B cap
Alnylam Pharmaceuticals Inc (ALNY) versus Vita Coco Company Inc (COCO) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Vita Coco Company Inc (COCO) is a beverages - non-alcoholic company listed on NASDAQ.
Latest reported ALNY revenue for 2024-12-31 was $2.25B. Net income was -$278.2M. Revenue was up 23.0% from 2023-12-31 to 2024-12-31. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
COCO does not have a complete income-statement cache yet.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. COCO currently screens at market cap $4.75B and trailing P/E 60.3.
Not investment advice. Open the ALNY and COCO stock pages for the full models.
Not investment advice.